Skip to main content
. Author manuscript; available in PMC: 2010 Jul 9.
Published in final edited form as: J Surg Res. 2008 Apr 10;148(1):31–37. doi: 10.1016/j.jss.2008.03.008

FIG 4.

FIG 4

VPA Inhibits Proliferation of SCLC Cells. DMS53 cells were treated with control (DMSO) or varying doses of VPA (1 to 10 mM) for up to 8 d and cell proliferation was measured by the MTT assay. VPA inhibited cell proliferation in a dose-dependent and statistically-significant manner.